Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: Results of a six‐month, multicenter, randomized, double‐blind, controlled, phase IV trial
Year: 2007
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Arthritis & Rheumatism
DOI: 10.1002/art.23144
Authors: J. Braun, P. Kästner, P. Flaxenberg, J. Währisch, P. Hanke, W. Demary, U. von Hinüber, K. Rockwitz, W. Heitz, U. Pichlmeier, C. Guimbal‐Schmolck, A. Brandt, MC‐MTX.6/RH Study Group
Institutions: Rheumazentrum Ruhrgebiet, Medac (Germany)
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Keywords: methotrexate, subcutaneous administration, oral administration, route of administration, ACR20 response, treatment switching, disease duration, drug safety, adverse events, disease-modifying antirheumatic drugs, biologic-naive patients, prefilled syringes, dose escalation, clinical efficacy comparison
Open Access status: closed
OpenAlex ID: W2073596252
